The cholesterol controversy is over. Why did it take so long?
1989; Lippincott Williams & Wilkins; Volume: 80; Issue: 4 Linguagem: Inglês
10.1161/01.cir.80.4.1070
ISSN1524-4539
Autores Tópico(s)Lipoproteins and Cardiovascular Health
ResumoHomeCirculationVol. 80, No. 4The cholesterol controversy is over. Why did it take so long? Free AccessAbstractPDF/EPUBAboutView PDFSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessAbstractPDF/EPUBThe cholesterol controversy is over. Why did it take so long? D Steinberg D SteinbergD Steinberg Department of Medicine, University of California, San Diego, La Jolla 92093-0613. Originally published1 Oct 1989https://doi.org/10.1161/01.CIR.80.4.1070Circulation. 1989;80:1070–1078 Previous Back to top Next FiguresReferencesRelatedDetailsCited By Braunwald E (2021) Cholesterol: the race to the bottom, European Heart Journal, 10.1093/eurheartj/ehab446, 42:45, (4612-4613), Online publication date: 1-Dec-2021. Sadat Halder M and Kumar De S (2021) A RETROSPECTIVE COHORT STUDY TO UNDERSTAND THE AGE, GENDER AND RISK FACTORS PATTERN IN PATIENTS ATTENDING FOR CARDIAC REHABILITATION (CR) AFTER CORONARY ARTERY BYPASS GRAFTING (CABG) SURGERY, INDIAN JOURNAL OF APPLIED RESEARCH, 10.36106/ijar/5702089, (57-60), Online publication date: 1-Jul-2021. Martini C and Andreoletti M (2021) Genuine versus bogus scientific controversies: the case of statins, History and Philosophy of the Life Sciences, 10.1007/s40656-021-00456-w, 43:4, Online publication date: 1-Dec-2021. Giustina A, Adler R, Binkley N, Bollerslev J, Bouillon R, Dawson-Hughes B, Ebeling P, Feldman D, Formenti A, Lazaretti-Castro M, Marcocci C, Rizzoli R, Sempos C and Bilezikian J (2020) Consensus statement from 2nd International Conference on Controversies in Vitamin D, Reviews in Endocrine and Metabolic Disorders, 10.1007/s11154-019-09532-w, 21:1, (89-116), Online publication date: 1-Mar-2020. Pei G, Sun H, Dai Y, Liu X, Zhao Z and Jia P (2019) Investigation of multi-trait associations using pathway-based analysis of GWAS summary statistics, BMC Genomics, 10.1186/s12864-018-5373-7, 20:S1, Online publication date: 1-Feb-2019. Rosenblit P (2019) Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk, Current Diabetes Reports, 10.1007/s11892-019-1246-y, 19:12, Online publication date: 1-Dec-2019. Yvan-Charvet L and Cariou B (2018) Poststatin era in atherosclerosis management, Current Opinion in Lipidology, 10.1097/MOL.0000000000000505, 29:3, (246-258), Online publication date: 1-Jun-2018. Iqbal J, Qarni A and Hawwari A (2017) Regulation of Intestinal Cholesterol Absorption: A Disease Perspective, Advances in Biological Chemistry, 10.4236/abc.2017.71004, 07:01, (60-75), . Markossian T, Burge N, Ling B, Schneider J, Pacold I, Bansal V, Leehey D, Stroupe K, Chang A and Kramer H (2016) Controversies Regarding Lipid Management and Statin Use for Cardiovascular Risk Reduction in Patients With CKD, American Journal of Kidney Diseases, 10.1053/j.ajkd.2015.12.030, 67:6, (965-977), Online publication date: 1-Jun-2016. Pickrell J, Berisa T, Liu J, Ségurel L, Tung J and Hinds D (2016) Detection and interpretation of shared genetic influences on 42 human traits, Nature Genetics, 10.1038/ng.3570, 48:7, (709-717), Online publication date: 1-Jul-2016. Pedersen T (2016) The Success Story of LDL Cholesterol Lowering, Circulation Research, 118:4, (721-731), Online publication date: 19-Feb-2016. Malamed S and Orr D (2015) Chest Pain Medical Emergencies in the Dental Office, 10.1016/B978-0-323-17122-9.00026-3, (421-439), . Diamond D and Ravnskov U (2015) How statistical deception created the appearance that statins are safe and effective in primary and secondary prevention of cardiovascular disease, Expert Review of Clinical Pharmacology, 10.1586/17512433.2015.1012494, 8:2, (201-210), Online publication date: 4-Mar-2015. Sivasankaran S (2013) Heart-Healthy Diet Cardiovascular Diseases, 10.1201/b14663-20, (277-308), Online publication date: 16-Apr-2013. Farnier M (2013) Histoire des statines, Médecine des Maladies Métaboliques, 10.1016/S1957-2557(13)70529-7, 7:5, (407-412), Online publication date: 1-Oct-2013. Fogelstrand P and Borén J (2012) Retention of atherogenic lipoproteins in the artery wall and its role in atherogenesis, Nutrition, Metabolism and Cardiovascular Diseases, 10.1016/j.numecd.2011.09.007, 22:1, (1-7), Online publication date: 1-Jan-2012. Zhang Y, Breevoort S, Angdisen J, Fu M, Schmidt D, Holmstrom S, Kliewer S, Mangelsdorf D and Schulman I (2012) Liver LXRα expression is crucial for whole body cholesterol homeostasis and reverse cholesterol transport in mice, Journal of Clinical Investigation, 10.1172/JCI59817, 122:5, (1688-1699), Online publication date: 1-May-2012. Schwarz M and Kim J (2011) Emerging Therapeutic Approaches for Dyslipidemias Associated with High LDL and Low HDL Metabolic Syndrome, 10.1002/9780470910016.ch8, (199-234) Alshatwi A, Al Obaaid M, Al Sedairy S, Ramesh E and Lei K (2010) Black and green tea improves lipid profile and lipid peroxidation parameters in Wistar rats fed a high-cholesterol diet, Journal of Physiology and Biochemistry, 10.1007/s13105-010-0053-3, 67:1, (95-104), Online publication date: 1-Mar-2011. Navab M, Reddy S, Van Lenten B and Fogelman A (2011) HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms, Nature Reviews Cardiology, 10.1038/nrcardio.2010.222, 8:4, (222-232), Online publication date: 1-Apr-2011. Mullick A, Fu W, Graham M, Lee R, Witchell D, Bell T, Whipple C and Crooke R (2011) Antisense oligonucleotide reduction of apoB-ameliorated atherosclerosis in LDL receptor-deficient mice, Journal of Lipid Research, 10.1194/jlr.M011791, 52:5, (885-896), Online publication date: 1-May-2011. Franco M, Cooper R, Bilal U and Fuster V (2011) Challenges and Opportunities for Cardiovascular Disease Prevention, The American Journal of Medicine, 10.1016/j.amjmed.2010.08.015, 124:2, (95-102), Online publication date: 1-Feb-2011. Henkin Y (2008) Re-Evaluating Therapeutic Target Goals for Statin-Treated Patients, Journal of the American College of Cardiology, 10.1016/j.jacc.2008.05.018, 52:8, (633-635), Online publication date: 1-Aug-2008. Steinberg D (2007) Summing up The Cholesterol Wars, 10.1016/B978-012373979-7/50041-8, (195-204), . Steinberg D (2006) Thematic review series: The Pathogenesis of Atherosclerosis. An interpretive history of the cholesterol controversy, part V: The discovery of the statins and the end of the controversy, Journal of Lipid Research, 10.1194/jlr.R600009-JLR200, 47:7, (1339-1351), Online publication date: 1-Jul-2006. Sirtori C and Fumagalli R (2006) LDL-cholesterol lowering or HDL-cholesterol raising for cardiovascular prevention, Atherosclerosis, 10.1016/j.atherosclerosis.2005.10.024, 186:1, (1-11), Online publication date: 1-May-2006. Al-Azzawi F, Thompson J and Stevenson J (2006) Which progestogen is more likely to increase the risk of fatal myocardial infarction: A combination of epidemiological and trial evidence, Maturitas, 10.1016/j.maturitas.2005.10.004, 54:2, (154-163), Online publication date: 1-May-2006. Wahab M and Al-Azzawi F (2016) Current State of Hormone Replacement Therapy: The Case for Using Trimegestone, Women's Health, 10.2217/17455057.2.4.539, 2:4, (539-550), Online publication date: 1-Jul-2006. Steinberg D (2005) Thematic review series: The Pathogenesis of Atherosclerosis. An interpretive history of the cholesterol controversy: part II:the early evidence linking hypercholesterolemia to coronary disease in humans, Journal of Lipid Research, 10.1194/jlr.R400012-JLR200, 46:2, (179-190), Online publication date: 1-Feb-2005. Navare S and Thompson P (2005) Pharmacological Treatments of Lipid Abnormalities Lipid Metabolism and Health, 10.1201/9781420038422.ch10, (183-212), Online publication date: 15-Dec-2005. Rahman S, Van Dam A, Schultzberg M and Crisby M (2005) High cholesterol diet results in increased expression of interleukin-6 and caspase-1 in the brain of apolipoprotein E knockout and wild type mice, Journal of Neuroimmunology, 10.1016/j.jneuroim.2005.07.018, 169:1-2, (59-67), Online publication date: 1-Dec-2005. Puskás L, Bereczki E, Sántha M, Vigh L, Csanádi G, Spener F, Ferdinandy P, Ónochy A and Kitajka K (2004) Cholesterol and cholesterol plus DHA diet-induced gene expression and fatty acid changes in mouse eye and brain, Biochimie, 10.1016/j.biochi.2004.10.004, 86:11, (817-824), Online publication date: 1-Nov-2004. Luo T, Wu C, Liu Y, Fu Y and Su M (2004) Dietary cholesterol affects sympathetic nerve function in rabbit hearts, Journal of Biomedical Science, 10.1007/BF02254438, 11:3, (339-345), Online publication date: 1-May-2004. Casserly I and Topol E (2004) Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins, The Lancet, 10.1016/S0140-6736(04)15900-X, 363:9415, (1139-1146), Online publication date: 1-Apr-2004. Tobert J (2003) Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors, Nature Reviews Drug Discovery, 10.1038/nrd1112, 2:7, (517-526), Online publication date: 1-Jul-2003. Hasselwander O, Krämer K, Hoppe P, Oberfrank U, Baldenius K, Schröder H, Kaufmann W, Bahnemann R and Nowakowsky B (2002) Effects of feeding various tocotrienol sources on plasma lipids and aortic atherosclerotic lesions in cholesterol-fed rabbits, Food Research International, 10.1016/S0963-9969(01)00192-2, 35:2-3, (245-251), Online publication date: 1-Jan-2002. Steinberg D (2002) Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crime, Nature Medicine, 10.1038/nm1102-1211, 8:11, (1211-1217), Online publication date: 1-Nov-2002. Rauoof M, Iqbal K, Mir M and Tramboo N (2001) Measurement of plasma lipids in patients admitted with acute myocardial infarction or unstable angina pectoris, The American Journal of Cardiology, 10.1016/S0002-9149(01)01613-7, 88:2, (165-167), Online publication date: 1-Jul-2001. Sempos C, Liu K and Ernst N (1999) Food and nutrient exposures: what to consider when evaluating epidemiologic evidence, The American Journal of Clinical Nutrition, 10.1093/ajcn/69.6.1330S, 69:6, (1330S-1338S), Online publication date: 1-Jun-1999. Newman P (1999) Can reduced folic acid and vitamin B12 levels cause deficient DNA methylation producing mutations which initiate atherosclerosis?, Medical Hypotheses, 10.1054/mehy.1998.0794, 53:5, (421-424), Online publication date: 1-Nov-1999. Taskinen and Smith (2002) Lipid disorders in NIDDM: implications for treatment, Journal of Internal Medicine, 10.1046/j.1365-2796.1998.00397.x, 244:5, (361-370), Online publication date: 1-Nov-1998. Hammad S, Siegel H and Marks H (1998) Total Cholesterol, Total Triglycerides, and Cholesterol Distribution Among Lipoproteins as Predictors of Atherosclerosis in Selected Lines of Japanese Quail, Comparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology, 10.1016/S1095-6433(97)00455-8, 119:2, (485-492), Online publication date: 1-Feb-1998. Selley M, Bartlett M, Czeti A and Ardlie N (1998) The role of (E)-4-hydroxy-2-nonenal in platelet activation by low density lipoprotein and iron, Atherosclerosis, 10.1016/S0021-9150(98)00123-3, 140:1, (105-112), Online publication date: 1-Sep-1998. Blann A, Davis A, Miller J and McCollum C (1997) Von Willebrand factor and soluble E-selectin in hyperlipidaemia: Relationship to lipids and vascular disease, American Journal of Hematology, 10.1002/(SICI)1096-8652(199705)55:1 3.0.CO;2-6, 55:1, (15-23), Online publication date: 1-May-1997. Blann A (1997) von Willebrand factor and soluble E-selectin in the prediction of cardiovascular disease progression in hyperlipidaemia, Atherosclerosis, 10.1016/S0021-9150(97)00081-6, 132:2, (151-156), Online publication date: 25-Jul-1997. Di Minno G, Mancini F and Margaglione M (1997) Hemostatic variables and ischemic cardiovascular disease: Do we need a concerted effort for more profitable future clinical investigations?, Cardiovascular Drugs and Therapy, 10.1007/BF00053032, 10:6, (743-749), Online publication date: 1-Jan-1997. LI S, CHERIAN G and SIM J (1996) Cholesterol Oxidation in Egg Yolk Powder During Storage and Heating as Affected by Dietary Oils and Tocopherol, Journal of Food Science, 10.1111/j.1365-2621.1996.tb12189.x, 61:4, (721-725), Online publication date: 1-Jul-1996. Wardle J (1995) Cholesterol and psychological well-being, Journal of Psychosomatic Research, 10.1016/0022-3999(94)00169-3, 39:5, (549-562), Online publication date: 1-Jul-1995. Watt F, Selley M, Thong P and Tang S (1995) Nuclear microscopy of atherosclerotic tissue, Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms, 10.1016/0168-583X(95)00589-7, 104:1-4, (356-360), Online publication date: 1-Sep-1995. Selley M, Czeti A, McGuiness J and Ardlie N (1994) Dipyridamole inhibits the oxidative modification of low density lipoprotein, Atherosclerosis, 10.1016/0021-9150(94)90194-5, 111:1, (91-97), Online publication date: 1-Nov-1994. Kuller L (1994) Eating fat or being fat and risk of cardiovascular disease and cancer among women, Annals of Epidemiology, 10.1016/1047-2797(94)90057-4, 4:2, (119-127), Online publication date: 1-Mar-1994. Lewis J and Taylor R (1994) Localization of lipoprotein in pre- and post-transition atherosclerotic lesions following short-term incubation with [125I]LDL, The Histochemical Journal, 10.1007/BF00162928, 26:11, (833-843), Online publication date: 1-Nov-1994. Gefeller O and Muche R (1994) Statistical Measures to Quantify the Benefit from Screening: a Case Study on Cholesterol Screening Information Systems and Data Analysis, 10.1007/978-3-642-46808-7_41, (436-444), . Aro A (2009) Diet and Chronic Disease: Selected Topics on Recent Advances, Annals of Medicine, 10.3109/07853899409148364, 26:6, (427-428), Online publication date: 1-Jan-1994. Suckling K (1994) Atherosclerosis Patents: Clues to the Next Drug Generation, Nature Biotechnology, 10.1038/nbt1294-1379, 12:12, (1379-1380), Online publication date: 1-Dec-1994. Superko H and Krauss R (1994) Coronary artery disease regression. Convincing evidence for the benefit of aggressive lipoprotein management., Circulation, 90:2, (1056-1069), Online publication date: 1-Aug-1994. Wiklund O, Angelin B, Bergman M, Berglund L, Bondjers G, Carlsson A, Linden T, Miettinen T, Ödman B, Olofsson S, Saarinen I, Sipilä R, Sjöström P, Kron B, Vanhanen H and Wright I (1993) Pravastatin and gemfibrozil alone and in combination for the treatment of hypercholesterolemia, The American Journal of Medicine, 10.1016/0002-9343(93)90114-5, 94:1, (13-20), Online publication date: 1-Jan-1993. BINI A and KUDRYK B (1992) Fibrin and Its Derivatives in the Normal and Diseased Vessel Wall, Annals of the New York Academy of Sciences, 10.1111/j.1749-6632.1992.tb51604.x, 667:1 Plasminogen A, (112-126), Online publication date: 1-Dec-1992. Kaplan N (2009) Lipid Intervention Trials in Primary Prevention: A Critical Review, Clinical and Experimental Hypertension. Part A: Theory and Practice, 10.3109/10641969209036175, 14:1-2, (109-118), Online publication date: 1-Jan-1992. Ryan T and Aust S (2008) The Role of Iron in Oxygen-Mediated Toxicities, Critical Reviews in Toxicology, 10.3109/10408449209146308, 22:2, (119-141), Online publication date: 1-Jan-1992. Durrington P and Bhatnagar D (1992) Wrong lesson from Finnish trial of cardiovascular disease prevention, The Lancet, 10.1016/0140-6736(92)91089-Q, 339:8791, (488), Online publication date: 1-Feb-1992. Rosenfeld M, Carew T, von Hodenberg E, Pittman R, Ross R and Steinberg D (1992) Autoradiographic analysis of the distribution of 125I-tyramine-cellobiose-LDL in atherosclerotic lesions of the WHHL rabbit., Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 12:8, (985-995), Online publication date: 1-Aug-1992. Faggiotto A (1991) Therapy of Atherosclerosis: When? Adalat, 10.1007/978-3-642-85498-9_20, (169-179), . Steinberg D (1991) OXIDATIVE MODIFICATION OF LOW DENSITY LIPOPROTEIN Oxidative Damage & Repair, 10.1016/B978-0-08-041749-3.50052-8, (267-272), . Durrington P (1991) Specific lipid lowering therapy in the management of diabetes., Postgraduate Medical Journal, 10.1136/pgmj.67.792.947, 67:792, (947-952), Online publication date: 1-Oct-1991. Ylä-Herttuala S (2009) Macrophages and Oxidized Low Density Lipoproteins in the Pathogenesis of Atherosclerosis, Annals of Medicine, 10.3109/07853899109150518, 23:5, (561-567), Online publication date: 1-Jan-1991. Nakandakare E, Garcia R and Quintão E (2012) Long Term Treatment of Hypercholesterolaemia with Simvastatin, Drug Investigation, 10.1007/BF03259538, 3:1, (34-38), Online publication date: 1-Feb-1991. Cohn J (2018) Treatment of patients with heart failure., Circulation, 81:4, (1440-1441), Online publication date: 1-Apr-1990.Dock D (2018) The cholesterol controversy., Circulation, 81:4, (1440-1440), Online publication date: 1-Apr-1990. Nishida M, Ando M, Iwamoto Y, Tsuchiya K and Nitta K (2016) New Insight into Atherosclerosis in Hemodialysis Patients: Overexpression of Scavenger Receptor and Macrophage Colony-Stimulating Factor Genes, Nephron Extra, 10.1159/000448486, 6:2, (22-30) October 1, 1989Vol 80, Issue 4 Advertisement Article InformationMetrics Copyright © 1989 by American Heart Associationhttps://doi.org/10.1161/01.CIR.80.4.1070 Originally publishedOctober 1, 1989 PDF download Advertisement
Referência(s)